These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3345969)

  • 21. Urinary excretion of benzo[a]pyrene metabolites following intravenous, oral, and cutaneous benzo[a]pyrene administration.
    Bouchard M; Viau C
    Can J Physiol Pharmacol; 1997 Mar; 75(3):185-92. PubMed ID: 9164700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of blood protein and target organ DNA and protein binding following topical application of benzo[a]pyrene and 7H-dibenzo[c,g]carbazole to mice.
    Meier JR; Warshawsky D
    Carcinogenesis; 1994 Oct; 15(10):2233-40. PubMed ID: 7955059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of glucuronidation of benzo(a)pyrene phenols by long-chain fatty acids.
    Zhong Z; Kauffman FC; Thurman RG
    Cancer Res; 1991 Sep; 51(17):4511-5. PubMed ID: 1908348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of fatty acids on formation, distribution, storage, and release of benzo(a)pyrene phenols and glucuronides in the isolated perfused rat liver.
    Zhong Z; Gao W; Kauffman FC; Thurman RG
    Cancer Res; 1989 Apr; 49(8):2012-6. PubMed ID: 2702643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of vitamin A deficiency on pulmonary and hepatic in vitro metabolism of benzo(a)pyrene in rat.
    Dogra SC; Khanduja KL; Sharma RR; Hom T; Varanasi U
    Biochem Int; 1985 Dec; 11(6):869-84. PubMed ID: 3937530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of benzo(a)pyrene metabolite: DNA adducts in selected hepatic and pulmonary cell types isolated from [3H]benzo(a)pyrene-treated rabbits.
    Horton JK; Rosenior JC; Bend JR; Anderson MW
    Cancer Res; 1985 Aug; 45(8):3477-81. PubMed ID: 3926299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo DNA adduct formation by benzo(a)pyrene in mouse and rat epidermal and dermal fibroblasts after topical application of an initiating dose of benzo(a)pyrene.
    Alexandrov K; Rojas-Moreno M
    Arch Geschwulstforsch; 1990; 60(5):329-40. PubMed ID: 2241509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intratracheally instilled benzo(a)pyrene on the pulmonary and hepatic drug-metabolizing enzymes in normal and vitamin A deficient rats.
    Dogra SC; Khanduja KL; Sharma RR
    Biochem Int; 1985 Mar; 10(3):373-83. PubMed ID: 4015664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary excretion kinetics of pyrene and benzo(a)pyrene metabolites following intravenous administration of the parent compounds or the metabolites.
    Bouchard M; Viau C
    Toxicol Appl Pharmacol; 1996 Aug; 139(2):301-9. PubMed ID: 8806846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-cyclodextrin reduces bioavailability of orally administered [3H]benzo[a]pyrene in the rat.
    Westerberg G; Wiklund L
    J Pharm Sci; 2005 Jan; 94(1):114-9. PubMed ID: 15761935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzo(a)pyrene disposition and metabolism in rats following intratracheal instillation.
    Weyand EH; Bevan DR
    Cancer Res; 1986 Nov; 46(11):5655-61. PubMed ID: 3756912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar bioavailability and lymphatic transport of benzo(a)pyrene when administered to rats in different amounts of dietary fat.
    Laher JM; Rigler MW; Vetter RD; Barrowman JA; Patton JS
    J Lipid Res; 1984 Dec; 25(12):1337-42. PubMed ID: 6530591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1983 Apr; 225(1):121-5. PubMed ID: 6300370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absorption, degradation and excretion of benzo(a)pyrene in the cricket (Acheta domesticus).
    Kumi CO; Nicholson RA; Law FC
    Xenobiotica; 1991 Oct; 21(10):1357-62. PubMed ID: 1796612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzo(a)pyrene phenol production by perfused rat liver and its inhibition by ethanol.
    Reinke LA; McManus P; Kauffman FC; Thurman RG
    Cancer Res; 1982 May; 42(5):1681-5. PubMed ID: 6279282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of pulmonary benzo[a]pyrene metabolism by reactive oxygen metabolites.
    Flowers NL; Miles PR
    Toxicology; 1991; 68(3):259-74. PubMed ID: 1654602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BP metabolism and the in vivo binding to hepatic DNA of rats fed diets containing menhaden fish oil.
    Dharwadkar SM; Wade AE
    Nutr Cancer; 1987; 10(3):163-70. PubMed ID: 3498153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of benzo[a]pyrene in the rat.
    Moir D; Viau A; Chu I; Withey J; McMullen E
    J Toxicol Environ Health A; 1998 Apr; 53(7):507-30. PubMed ID: 9561966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The formation of genotoxic metabolites of benzo[a]pyrene by the isolated perfused rat liver, as detected by the bioluminescence test.
    Ben-Itzhak J; Levi BZ; Shor R; Lanir A; Bassan HM; Ulitzur S
    Mutat Res; 1985 Jun; 147(3):107-12. PubMed ID: 4000152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.